Doctor's reference on last days of Srividya sparks row

Image
Press Trust of India Thiruvananthapuram
Last Updated : Nov 15 2013 | 3:59 PM IST
The memoirs of an eminent oncologist, who treated South Indian actress Srividya, who died of cancer seven years ago, has sparked a row over the allegation that a trust, which managed her assets, showed reluctance to bear the expenses of some costly medicines.
Former Director of Regional Cancer Centre (RCC), Dr M Krishnan Nair, claimed in his recently released book that the Srividya Trust was unwilling to buy the medicines though doctors suggested that they would improve her condition.
Incidentally, the trust was headed by former minister and actor K B Ganesh Kumar, though Nair does not mention any name in his book.
Asked about Nair's claim, a spokesperson for Ganesh Kumar dubbed it as a "big lie". "This allegation is totally false. The functioning of the trust is transparent and everyone is aware of that. This could be seen only as an attempt to tarnish the image of Kumar," he said.
Srividya, who essayed many memorable roles in various South Indian movies, died at the RCC at the age of 53 on October 19, 2006.
Nair's memoirs in Malayalam, said the doctors of RCC decided to give a new medicine to Srividya which had comparatively less side-effects on lungs.
As it would cost around Rs one lakh per injection, the doctors asked the actress whether she could bear the cost. Srividya then informed the doctors that all her assets had been transferred to a trust named after her and it should bear the treatment expenses, the doctor claimed in the book.
Though doctors contacted the trust members, they said they could not bear the huge cost of the medicines and that any other kind of treatment was enough for the actress, the book claimed.
The doctor also noted that the actress, known for her charming personality and graceful looks, had apprehensions and misconceptions about the cancer treatment.
As any other ordinary woman, she was also afraid of the side-effects of the medicine, thinking it might cause changes in her appearance, he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 15 2013 | 3:59 PM IST

Next Story